FindTrial
Sign In

Nasal Potential Difference in suspected CF patients with 5T polymorphism * Comparison between patients from Israel and Netherlands

Nasal Potential Difference in suspected CF patients with 5T polymorphism * Comparison between patients from Israel and Netherlands - NPD in 5T patients

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON39838
Enrollment
30
Registered
2013-09-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic Fibrosis Mucoviscidosis

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: presence of 5T polymorphism on one or both alleles

Exclusion criteria

Exclusion criteria: chronic irritation of nasal epithelium

Design outcomes

Primary

MeasureTime frame
Potential differences in NPD measurement.—

Secondary

MeasureTime frame
None.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)